| Title |
Pharmacologic Boosting of Atazanavir in Maintenance HIV-1 Therapy: The COREYA Propensity-Score Adjusted Study
|
|---|---|
| Published in |
PLOS ONE, November 2012
|
| DOI | 10.1371/journal.pone.0049289 |
| Pubmed ID | |
| Authors |
Laurent Hocqueloux, Philippe Choisy, Gwenaël Le Moal, Françoise Borsa-Lebas, David Plainchamp, Eric Legac, Thierry Prazuck, Xavier de la Tribonnière, Yazdan Yazdanpanah, Jean-Jacques Parienti |
| Abstract |
Among HIV-1 infected patients who achieved virologic suppression, the use of atazanavir without pharmacologic boosting is debated. We evaluated the efficacy and tolerance of maintenance therapy with unboosted atazanavir in clinical practice. |
Mendeley readers
The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 1 | 11% |
| Unknown | 8 | 89% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 3 | 33% |
| Student > Master | 3 | 33% |
| Other | 1 | 11% |
| Professor | 1 | 11% |
| Unknown | 1 | 11% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 6 | 67% |
| Nursing and Health Professions | 1 | 11% |
| Unknown | 2 | 22% |